CDIO
CDIO
NASDAQ · Biotechnology

Cardio Diagnostics Holdings

$2.08
+0.07 (+3.48%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,488.0% upside
Low Target $21.42
Average Target $33.03
High Target $37.66
Current Price $2.08
Current
$2.08
Target
$33.03
$21.42 $33.03 avg $37.66
Scenario Analysis
Bear Case
$21.42
929.8%
Low target
Base Case
$33.03
+1,488.0%
Avg target
Bull Case
$37.66
+1,710.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$7.91
-73.7% from high
52-Week Low
$0.97
+114.4% from low
Target vs 52W High
$33.03
+317.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%